Charles Rosier's guest appearances

Charles Rosier

The Glossy Beauty Podcast

Beyond The Beauty with Bobbi Brown

Skincare Anarchy

Augustinus Bader

Divya Gugnani

Annie Kreighbaum

Greg Gonzalez

Mark Curry

Katherine Power

Victoria Beckham

Casey Georgeson

Rebecca Zhou

Saint Jane

Annie Jackson

Sheena Yaitanes

Shani Darden

Colette Laxton

Sarah Creal

OwlTail

Charles Rosier is the CEO and Co- Founder of Augustinus Bader. Prior to that he was a Managing Director at Goldman Sachs and an investor in Biotechnology.Charles Rosier chose to apply his financial background and network to become involved in investments that would contribute to research solutions for medical conditions as well as environmental and humanitarian causes. His most recent investment endeavor includes a joint business venture with Augustinus Bader, a prominent German professor who has conducted studies involving regenerative medicine and stem cell research for the past three decades. In 2007, Bader constituted a hydrogel utilizing revolutionary stem cell science that eliminates the need for skin grafts, scar revision and minimizes opportunistic infections that can create a circle of trauma for burn victims.Realizing the potential of this breakthrough, Rosier partnered with Professor Bader to form the Bader Group, a business model structured around maximizing biomedical research and biotechnological treatments across a broad spectrum of interventions and diseases. --- Send in a voice message: https://podcasters.spotify.com/pod/show/skincareanarchy/messageSupport this podcast: https://podcasters.spotify.com/pod/show/skincareanarchy/supportSupport the showFollow The Show On All Socials Using The Tag @skincareanarchy

Charles Rosier is the CEO and Co- Founder of Augustinus Bader. Prior to that he was a Managing Director at Goldman Sachs and an investor in Biotechnology.Charles Rosier chose to apply his financial background and network to become involved in investments that would contribute to research solutions for medical conditions as well as environmental and humanitarian causes. His most recent investment endeavor includes a joint business venture with Augustinus Bader, a prominent German professor who has conducted studies involving regenerative medicine and stem cell research for the past three decades. In 2007, Bader constituted a hydrogel utilizing revolutionary stem cell science that eliminates the need for skin grafts, scar revision and minimizes opportunistic infections that can create a circle of trauma for burn victims.Realizing the potential of this breakthrough, Rosier partnered with Professor Bader to form the Bader Group, a business model structured around maximizing biomedical research and biotechnological treatments across a broad spectrum of interventions and diseases. --- Send in a voice message: <a href="https://podcasters.spotify.com/pod/show/skincareanarchy/messageSupport" rel="nofollow" target="_blank">https://podcasters.spotify.com/pod/show/skincareanarchy/messageSupport</a> this podcast: <a href="https://podcasters.spotify.com/pod/show/skincareanarchy/support" rel="payment nofollow" target="_blank">https://podcasters.spotify.com/pod/show/skincareanarchy/support</a><a href="https://www.buzzsprout.com/2206286/support" rel="payment nofollow" target="_blank">Support the show</a>Follow The Show On All Socials Using The Tag @skincareanarchy

Charles Rosier, Co-Founder and CEO of Augustinus Bader Skincare

If you know Bobbi, you know she swears by Augustinus Bader’s moisturizer. This week, she’s joined by Charles Rosier, the investor-turned-beauty-entrepreneur who kickstarted the cult-favorite skincare brand. It all started when Charles saw how Dr. Augustinus Bader’s stem cell wound gel prevented scarring, and wondered if it would also work on wrinkles—and from there, the revolutionary skincare line was born. This week, Charles joins Bobbi to talk about the science behind the serums, how a beauty brand can help fund stem cell research, and why when it comes to brand-building, good luck is nothing without hard work.   Learn more about your ad-choices at https://www.iheartpodcastnetwork.comSee omnystudio.com/listener for privacy information.

If you know Bobbi, you know she swears by Augustinus Bader’s moisturizer. This week, she’s joined by Charles Rosier, the investor-turned-beauty-entrepreneur who kickstarted the cult-favorite skincare brand. It all started when Charles saw how Dr. Augustinus Bader’s stem cell wound gel prevented scarring, and wondered if it would also work on wrinkles—and from there, the revolutionary skincare line was born. This week, Charles joins Bobbi to talk about the science behind the serums, how a beauty brand can help fund stem cell research, and why when it comes to brand-building, good luck is nothing without hard work.  Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com" rel="nofollow" target="_blank">https://www.iheartpodcastnetwork.com</a>See <a href="https://omnystudio.com/listener" rel="nofollow" target="_blank">omnystudio.com/listener</a> for privacy information.

Augustinus Bader Co-Founder Charles Rosier

Some beauty products trickle down from medical use to everyday consumers by happenstance, but Augustinus Bader's skincare line is the opposite, according to the company's CEO Charles Rosier.Rosier first learned about Professor Augustinus Bader's research around a "wound gel" in a case study involving a young burn victim. "Basically, using that wound gel [Augustinus] was able to prevent skin graft and scarring to that child," Rosier said on the Glossy Beauty Podcast. "I was really shocked that the thing could exist, but was not widely available."As Bader -- a professor of stem cell biology at Germany's University of Leipzig -- told Rosier then, he felt that pharmaceutical companies weren't as willing to fund clinical trials because "the number of cases of burned people in the Western world was not so high. Most cases are actually in the third world," he said. "For a pharmaceutical group, it's not necessarily the most valuable customer."Rosier decided to step in and co-found a consumer-centric version of the company in 2018. He thought a skincare brand could help fuel Bader's greater work -- "he's the brain doing the research, I'm the guy behind the scenes," he said. The line has gone on to earn accolades among Hollywood celebrities for its rejuvenating effect, not just its medical expertise. That was by design -- in lieu of a pricy marketing campaigns or influencers, the company distributed samples through a personal connection in Los Angeles in its early days.Since then, Augustinus Bader has slowly added new products to its line-up to complement its cult status "The Cream" and "The Rich Cream," which retail for $265. The company expects to earn $70 million in 2020, up from an estimated $24 million in 2019 -- but Rosier doesn't see the company putting dozens of products on store shelves (or online, where it makes most of its sales), despite the demand."We can't lie about it. That product is efficient on its own and it nourishes the skin cells' environment so your skin cells make the right decision," Rosier said.

Some beauty products trickle down from medical use to everyday consumers by happenstance, but Augustinus Bader's skincare line is the opposite, according to the company's CEO Charles Rosier.Rosier first learned about Professor Augustinus Bader's research around a "wound gel" in a case study involving a young burn victim. "Basically, using that wound gel [Augustinus] was able to prevent skin graft and scarring to that child," Rosier said on the Glossy Beauty Podcast. "I was really shocked that the thing could exist, but was not widely available."As Bader -- a professor of stem cell biology at Germany's University of Leipzig -- told Rosier then, he felt that pharmaceutical companies weren't as willing to fund clinical trials because "the number of cases of burned people in the Western world was not so high. Most cases are actually in the third world," he said. "For a pharmaceutical group, it's not necessarily the most valuable customer."Rosier decided to step in and co-found a consumer-centric version of the company in 2018. He thought a skincare brand could help fuel Bader's greater work -- "he's the brain doing the research, I'm the guy behind the scenes," he said. The line has gone on to earn accolades among Hollywood celebrities for its rejuvenating effect, not just its medical expertise. That was by design -- in lieu of a pricy marketing campaigns or influencers, the company distributed samples through a personal connection in Los Angeles in its early days.Since then, Augustinus Bader has slowly added <a href="https://www.glossy.co/beauty/augustinus-bader-makes-widest-product-push-yet" rel="nofollow" target="_blank">new products</a> to its line-up to complement its cult status "The Cream" and "The Rich Cream," which retail for $265. The company expects to earn $70 million in 2020, up from an <a href="https://www.voguebusiness.com/beauty/augustinus-bader-building-a-modern-luxury-skincare-brand-covid-19" rel="nofollow" target="_blank">estimated</a> $24 million in 2019 -- but Rosier doesn't see the company putting dozens of products on store shelves (or online, where it makes most of its sales), despite the demand."We can't lie about it. That product is efficient on its own and it nourishes the skin cells' environment so your skin cells make the right decision," Rosier said.

'We don't want to be La Mer': Augustinus Bader CEO Charles Rosier on creating the next cult beauty brand